SOURCE: Milestone Scientific, Inc.

Milestone Scientific, Inc.

November 07, 2014 10:45 ET

Milestone Scientific to Present at the SeeThruEquity Microcap Investor Conference in NYC

LIVINGSTON, NJ--(Marketwired - November 07, 2014) - Milestone Scientific Inc. (OTCQB: MLSS), a medical R&D company that designs, patents, incubates and commercializes a growing portfolio of innovative injection technologies, today announced that management will present at the SeeThruEquity Microcap Investor Conference on Wednesday, November 12th at 3:00 P.M. EST at the Convene Midtown East in New York City located at 730 Third Avenue.

The webcast and a copy of the Company's slide presentation will be available on the investor relations section of the Company's website at

Members of the investment community interested in meeting with the Company's management during the conference can contact a representative at SeeThruEquity and can register to attend for the conference at the following link:

About SeeThruEquity

SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The Company's research is not paid for and is unbiased as it does not conduct any investment banking or commission based business. SeeThruEquity's research is contributed to by Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distributed to its opt-in investors along with Thomson Estimates, the leading estimates platform on Wall Street. 

SeeThruEquity Conferences are held approximately every quarter throughout the year and host industry professionals and investors who are looking for new ideas, opportunities, and corporate relationships. For more information, visit

About Milestone Scientific Inc.
Milestone Scientific Inc. (MLSS) is a leading medical research and development company that designs and patents innovative injection technology. Milestone's computer-controlled systems make injections precise, efficient, and virtually painless. For more information please visit our website:

Contact Information